Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis.

MLA

Simillis, C., et al. “Postoperative Chemotherapy Improves Survival in Patients with Resected High‐risk Stage II Colorectal Cancer: Results of a Systematic Review and Meta‐analysis.” Colorectal Disease, vol. 22, no. 10, Oct. 2020, pp. 1231–44. EBSCOhost, https://doi.org/10.1111/codi.14994.

APA

Simillis, C., Singh, H. K. S. I., Afxentiou, T., Mills, S., Warren, O. J., Smith, J. J., Riddle, P., Adamina, M., Cunningham, D., & Tekkis, P. P. (2020). Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis. Colorectal Disease, 22(10), 1231–1244. https://doi.org/10.1111/codi.14994

Chicago

Simillis, C., H. K. S. I. Singh, T. Afxentiou, S. Mills, O. J. Warren, J. J. Smith, P. Riddle, M. Adamina, D. Cunningham, and P. P. Tekkis. 2020. “Postoperative Chemotherapy Improves Survival in Patients with Resected High‐risk Stage II Colorectal Cancer: Results of a Systematic Review and Meta‐analysis.” Colorectal Disease 22 (10): 1231–44. doi:10.1111/codi.14994.